Bellevue Group AG
Top Portfolio Positions
154 positions ·
$4,371,089,810 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
681,908 | $304,499,197 | 6.97% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
13,452,288 | $263,126,752 | 6.02% | |
| ARGX |
Argenx SE
Healthcare
|
313,000 | $228,568,250 | 5.23% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
278,674 | $215,314,678 | 4.93% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
3,584,573 | $176,217,608 | 4.03% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
1,169,879 | $163,046,036 | 3.73% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
1,544,456 | $150,198,346 | 3.44% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
1,818,665 | $136,563,554 | 3.12% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
286,654 | $132,144,627 | 3.02% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
481,785 | $124,454,701 | 2.85% |
Portfolio Trend
25 quarters · across all stocks
Holdings in RLAY
Shares Held
Position Value (USD)
23 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $77,562,657 | 7,795,242 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $70,601,779 | 8,345,364 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $43,564,083 | 8,345,610 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $28,478,809 | 8,230,870 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $19,328,505 | 7,377,292 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $30,394,443 | 7,377,292 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $52,230,462 | 7,377,184 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $41,578,789 | 6,377,115 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $49,190,929 | 5,926,618 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $65,356,262 | 5,936,082 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $41,082,850 | 4,885,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $52,385,248 | 4,170,800 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $68,722,722 | 4,172,600 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $62,820,010 | 4,204,820 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $94,061,823 | 4,204,820 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $67,540,388 | 4,032,262 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $117,294,532 | 3,918,962 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $126,094,093 | 4,105,962 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $118,425,481 | 3,755,962 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $96,632,799 | 2,640,962 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $66,766,562 | 1,931,344 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $58,572,876 | 1,409,357 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $55,367,000 | 1,300,000 | Shares | Defined | 2020-11-16 | |
| No 13F history on record for this holder in this stock. | ||||||